Navigation Links
Catalent to Debate Logistics of Delivery and Transportation of Cell and Gene Therapies at HPCLC
Date:10/22/2019

Catalent, a global leader in clinical supply services, today announced that Ann McMahon, Program Director, Clinical Supply Services and Drug Product Technologies Integration, will participate in a panel session titled “Cell and Gene Therapy Logistics” at the upcoming Health and Personal Care Logistics Conference (HPCLC), to be held at the Gwen Hotel, Chicago, on Oct. 28-30, 2019.

The panel session, on Wednesday, Oct. 30 at 8:30 a.m., comes at a time when there is an increasing focus on individualizing patient care, and panelists will discuss the critical logistics of delivery and transportation as patient care changes; and as cell, gene and biologics therapies constitute an ever-increasing share of treatments. The panelists will also explore future transportation demands.

Ms. McMahon has over 17 years of experience in the pharmaceutical industry. Prior to joining Catalent, she was Manager, New Product Launch at West-Ward Pharmaceuticals, and also Boehringer Ingelheim. She holds a bachelor’s degree in biology/biochemistry from Ohio Northern University, Ada, Ohio; and a master’s degree in clinical pharmacology from the Ohio State University, Columbus, Ohio.

For further information, visit https://www.hpclcnet.org/.

To arrange a meeting with Ms. McMahon at the event, contact Richard Kerns at NEPR - richard@nepr.agency.

About Catalent
Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs nearly 13,000 people, including approximately 2,400 scientists, at more than 35 facilities across five continents, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Read the full story at https://www.prweb.com/releases/catalent_to_debate_logistics_of_delivery_and_transportation_of_cell_and_gene_therapies_at_hpclc/prweb16662663.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Catalent and Minerva Neurosciences Enter Commercial Supply Agreement for Schizophrenia Drug Roluperidone
2. Advantages of Singapore as a Clinical Supply Hub to be Discussed by Catalent at Accelerating Clinical Trials in Asia Conference
3. Flexible Filling and Adoption of ‘Ready-to-Use’ Technologies to be Discussed by Catalent Biologics at the Pharma Forum
4. Catalent Expert to Discuss the Importance of Formulation to Benefit Diabetes Patients at NLS Days
5. Catalent Biologics Announces Agreement to Provide Additional Production of Approved Gene Therapy Treatment for Spinal Muscular Atrophy
6. IVERIC bio Enters into Strategic Manufacturing Relationship with Catalent’s Paragon Gene Therapy for Orphan Inherited Retinal Diseases
7. Patient-Focused Drug Delivery to be Presented by Catalent at PODD
8. Lipid-Based Drug Delivery in Modern Pharmaceutical Development to be Presented by Catalent and BASF at Forthcoming Workshop
9. Catalent Biologics Announces Collaboration with Therachon, Switzerland, to Advance Clinical Development of Innovative Protein Therapy for Achondroplasia
10. Catalent Executives to Present on Clinical Trial Supply Management and Optimizing Product Development at Upcoming BioPharma Asia Conference
11. Portages Biohaven enters into exclusive formulation agreement and global license with Catalent for lead product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/12/2019)... ... November 12, 2019 , ... ... the food and beverage industry launched a new innovative website. , After extensive ... Now, the website offers global visitors updated ingredient usage tables by food application ...
(Date:11/6/2019)... ... ... Diversified Technologies, Inc. has introduced a PEF production system for ... processing. , The DTI Industrial PEF Unit can pre-treat whole pieces of fruits and ... up to 50% and achieve up to an 80% reduction of drying energy. ...
(Date:11/5/2019)... ... ... was demonstrating signs of osteoarthritis in April 2019. He was lame and stiff and ... play were normal, it was clear that he was in pain. , Ole’s owner took ... Center in San Diego, California. Dr. Mullen is an experienced VetStem user and ...
(Date:10/30/2019)... ... October 30, 2019 , ... While using cold plasma to kill cancer cells ... Dakota School of Mines & Technology are exploring new ways to regulate cold ... , If successful, the technique would prove to be a drug-free, minimally invasive cancer ...
Breaking Biology Technology:
(Date:11/5/2019)... , ... November 05, 2019 , ... ... manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced ... at Hotel Sofia, Barcelona, Spain on Nov. 12 – 14, 2019. , On ...
(Date:10/30/2019)... Va. (PRWEB) , ... October 30, 2019 , ... ... offering from the Farm Credit Knowledge Center in which participants will learn about ... industry best practice relating to these technologies. , Participants will have the ...
(Date:10/29/2019)... ... October 29, 2019 , ... ... announced that Octapharma, one of the world’s largest human protein manufacturers, has ... manufacturing of therapeutic proteins addressing severe diseases in the areas of haematology, ...
Breaking Biology News(10 mins):